Emergency department visits for antibiotic-associated adverse events

Clinical Infectious Diseases

Volumn 47, Issue 6, 2008, Pages 735-743

  Shehab, Nadine ^a   Patel, Priti R ^a   Srinivasan, Arjun ^a   Budnitz, Daniel S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFDINIR; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; KETOLIDE; LEVOFLOXACIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM DERIVATIVE;

ALLERGIC REACTION; ALLERGIC VASCULITIS; AMBULATORY CARE; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; DERMATITIS; DISEASE SEVERITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INTERACTION; DRUG USE; EDEMA; EMERGENCY WARD; ERYTHEMA; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FACE EDEMA; FLUSHING; GASTROINTESTINAL TOXICITY; GENITAL EDEMA; HEALTH CARE PRACTICE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; MEASLES LIKE RASH; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROTOXICITY; OUTPATIENT CARE; PHARYNX DISEASE; PHARYNX EDEMA; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RED MAN SYNDROME; RESPIRATORY ARREST; RESPIRATORY DISTRESS; SERUM SICKNESS; SIDE EFFECT; STEVENS JOHNSON SYNDROME; UNSPECIFIED SIDE EFFECT; URTICARIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG HYPERSENSITIVITY; EMERGENCY SERVICE, HOSPITAL; HUMANS; PENICILLINS; UNITED STATES;

EID: 51549090562     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/591126     Document Type: Article

References (46)

1. Raofi S, Schappert SM. Medication therapy in ambulatory medical care: United States, 2003-04. Vital Health Stat 13 2006; 163:1-40.
2. Ma J, Stafford RS, Cockburn IM, Finkelstein SN. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. Clin Ther 2003; 25:1503-17.
3. Wise R, Hart T, Cars O, et al. Antimicrobial resistance is a major threat to public health. BMJ 1998; 317:609-10.
4. Harrison PF, Lederberg J, eds. Antimicrobial resistance: issues and options. Washington, DC: National Academy Press, 1998.
5. Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance: a call for action by clinicians, public health officials, and patients. JAMA 1997; 278:944-5.
6. Low DE, Scheld WM. Strategies for stemming the tide of antimicrobial resistance. JAMA 1998; 279:394-5.
7. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999; 43:459-65.
8. Alliance for the Prudent Use of Antibiotics. Available at: http://www.tufts.edu/med/apua/. Accessed 11 June 2007.
9. Department of Health and Human Services, Centers for Disease Control and Prevention. Get smart: know when antibiotics work. Available at: http://www.cdc.gov/drugresistance/community/. Accessed 11 June 2007.
10. US Consumer Product Safety Commission. National Electronic Injury Surveillance System all injury program sample design and implementation. Washington, DC: US Consumer Product Safety Commission, 2002.
11. Jhung MA, Budnitz DS, Mendelsohn AB, et al. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (NEISS-CADES). Med Care 2007; 45(Suppl 2):S96-102.
12. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296:1858-66.
13. National Center for Health Statistics. National Ambulatory Medical Care Survey: public use data file documentation: 2004. Hyattsville, MD: National Center for Health Statistics, 2006.
14. National Center for Health Statistics. National Hospital Ambulatory Medical Care Survey: public use data file documentation: 2004. Hyattsville, MD: National Center for Health Statistics, 2006.
15. National Center for Health Statistics. National Ambulatory Medical Care Survey: public use data file documentation: 2005. Hyattsville, MD: National Center for Health Statistics, 2006.
16. National Center for Health Statistics. National Hospital Ambulatory Medical Care Survey: public use data file documentation: 2005. Hyattsville, MD: National Center for Health Statistics, 2006.
17. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998; 279:875-7.
18. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33:757-62.
19. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA 2005; 294:2315-22.
20. Roumie CL, Halasa NB, Grijalva CG, et al. Trends in antibiotic prescribing for adults in the United States - 1995 to 2002. J Gen Intern Med 2005; 20:697-702.
21. National Center for Health Statistics, Centers for Disease Control and Prevention. NAMCS estimation procedures. Available at: http://www.cdc.gov/nchs/ about/major/ahcd/namcs_est_proc.htm. Accessed 30 May 2007.
22. National Center for Health Statistics, Centers for Disease Control and Prevention. NHAMCS estimation procedures. Available at: http://www.cdc.gov/nchs/ about/major/ahcd/nhamcs_est_proc.htm. Accessed 30 May 2007.
23. Kish L. Survey sampling. New York, NY: Wiley Inter-Science, 1995: 206-9.
24. Budnitz DS, Shehab N, Kegler SR, Richards CL. Emergency department visits for adverse drug events in older adults: the contribution of potentially inappropriate medication use. Ann Intern Med 2007; 147: 755-65.
25. Zhan C, Arispe I, Kelley E, et al. Ambulatory care visits for treating adverse drug effects in the United States, 1995-2001. Jt Comm J Qual Patient Saf 2005; 31:372-8.
26. Prescott WA Jr, DePestel DD, Ellis JJ, Regal RE. Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis 2004; 38: 1102-7.
27. Gholami K, Parsa S, Shalviri G, Sharifzadeh M, Assasi N. Anti-infectives-induced adverse drug reactions in hospitalized patients. Pharmacoepidemiol Drug Saf 2005; 14:501-6.
28. Sachs B, Riegel S, Seebeck J, et al. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf 2006; 29:1087-100.
29. Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis 2006; 42:1578-83.
30. Park-Wyllie LY, Juurlink DN, Kopp A, et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006; 354: 1352-61.
31. Gill JM, Fleischut P, Haas S, Pellini B, Crawford A, Nash DB. Use of antibiotics for adult respiratory infections in outpatient settings: a national ambulatory network study. Fam Med 2006; 38:349-54.
32. Metlay JP, Shea JA, Crossette LB, Asch DA. Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 2002; 17:87-94.
33. Wood F, Simpson S, Butler CC. Socially responsible antibiotic choices in primary care: a qualitative study of GPs' decisions to prescribe broad-spectrum and fluoroquinolone antibiotics. Fam Pract 2007; 24:427-34.
34. Leone R, Venegoni M, Motola D, et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf 2003; 26:109-20.
35. Powers JH. Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs. Clin Infect Dis 2007; 45:S153-62.
36. Hirschmann JV. Antibiotics for common respiratory tract infections in adults. Arch Intern Med 2002; 162:256-64.
37. Gilberg K, Laouri M, Wade S, Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescriptions drugs for asthma, depression, and CHF. J Manag Care Pharm 2003; 9:232-7.
38. Hickner J. A new look at an old problem: inappropriate antibiotics for acute respiratory tract infections. Ann Fam Med 2006; 4:484-5.
39. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ 1998; 317:637-42.
40. Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ 2003; 326:138.
41. Linder JA, Singer DE. Desire for antibiotics and antibiotic prescribing for adults with upper respiratory tract infections. J Gen Intern Med 2003; 18:795-801.
42. Wilson AA, Crane LA, Barrett PH Jr, Gonzales R. Public belief and use of antibiotics for acute respiratory illness. J Gen Intern Med 1999; 14:658-62.
43. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc 2008; 139(Suppl):3S-24S (erratum: J Am Dent Assoc 2008;139:253).
44. Gould FK, Elliott TSJ, Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society of Antimicrobial Chemotherapy. J Antimicrob Chemother 2006; 57: 1035-42.
45. Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimes. J Gen Intern Med 2005; 20:653-6.
46. Lin SJ, Lambert B, Tan H, Toh S. Frequency estimates from prescription drug datasets. Pharmacoepidemiol Drug Saf 2006; 15:512-20.